Paul Boucher
- Role
- CEO and President at Parion Sciences
- Location
- Raleigh, NC, US
- LinkedIn followers
- 500 followers
Experience
CEO and President
Apr 2014 — Present
Parion is a privately held, development stage pharmaceutical company focused is on treating unmet respiratory indications resulting from defects of the innate mucosal defense. Parion\'s pipeline includes a diverse range of novel small molecules for the treatment of Primary Ciliary Dyskinesia, Cystic Fibrosis, COPD, and Asthma. Our lead program, P-1037 Inhalation Solution, has the potential to be the first-in-class treatment for the severe, rare disease, Primary Ciliary Dyskinesia.
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.